Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 5,000 shares at $6.75 ($34K) on 2006-09-25, disclosed to the SEC on 2006-09-27.
Scheduled sale ($34k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.71 | 100 | $671 | 2.0% |
| 2 | $6.72 | 400 | $3K | 7.9% |
| 3 | $6.73 | 500 | $3K | 9.9% |
| 4 | $6.74 | 400 | $3K | 7.9% |
| 5 | $6.75 | 200 | $1K | 4.0% |
| 6 | $6.76 | 100 |
| $676 |
| 2.0% |
| 7 | $6.77 | 100 | $677 | 2.0% |
| 8 | $6.79 | 100 | $679 | 2.0% |
| 9 | $6.81 | 300 | $2K | 6.0% |
| 10 | $6.82 | 100 | $682 | 2.0% |
| 11 | $6.83 | 600 | $4K | 12.0% |
| 12 | $6.84 | 100 | $684 | 2.0% |
| 13 | $6.85 | 100 | $685 | 2.0% |
| 14 | $6.87 | 200 | $1K | 4.0% |
| 15 | $6.88 | 100 | $688 | 2.0% |
| 16 | $6.89 | 300 | $2K | 6.1% |
| 17 | $6.90 | 500 | $3K | 10.1% |
| 18 | $6.91 | 300 | $2K | 6.1% |
| 19 | $6.92 | 300 | $2K | 6.1% |
| 20 | $6.93 | 200 | $1K | 4.1% |
| Total | $6.82 avg | 5,000 | $34K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |